Lonza Inc.
90 Boroline Road
Allendale
New Jersey
07401
United States
Tel: 201-316-9200
Fax: 201-785-9989
Website: http://www.lonza.com/
Email: contact.allendale@lonza.com
57 articles about Lonza Inc.
-
Lonza Announces Results of the 2019 Annual General Meeting – All Motions Proposed by Board of Directors Accepted
4/18/2019
312 shareholders attended, representing 60% of the issued share capital
-
Lonza Inc. Pharma&Biotech Launches Ibex Solutions – An Innovative New Concept In Biological Manufacturing And Development
7/26/2017
-
Aurinia Announces Long-Term Manufacturing Collaboration Agreement With Lonza Inc. For Clinical And Commercial Supply Of Voclosporin
12/20/2016
-
Swiss Biotech Giant Lonza Inc. to Open New Facility in Houston Suburb, Will Hire 100 Initially But Hundreds of Jobs to Come
9/30/2016
-
Lonza Inc. to Buy InterHealth for as Much as $300 Million in Health Push
8/15/2016
-
Lonza Inc. Release: New e-Learning Module In The Lonza QC Insidertm Toolbox Helps Scientists Overcome Interference In The Bacterial Endotoxins Test
7/12/2016
-
Lonza Inc.’s 4D-NucleofectorTM LV Unit Delivers Closed, Optimized, Larger-Scale Transfection
6/8/2016
-
Lonza Inc. Prices CHF 325 Million Dual Tranche Straight Bonds
8/19/2015
-
Sunshine Biopharma, Inc. To Receive This Week A Sample From The Adva-27a Manufacturing Currently Underway At Lonza Inc. In Switzerland
5/27/2015
-
Lonza Inc. Hosts 1st Global Endotoxin Testing Summit
3/2/2015
-
Portola Pharmaceuticals, Inc. Announces Commercial Supply Agreement For Andexanet Alfa With Lonza Inc.
10/17/2014
-
Lonza Inc. Q1 Business Performance On Track
4/24/2014
-
Lonza Inc.'s Facility In Singapore Received Good Manufacturing Practice (GMP) Certification From The HSA
4/17/2014
-
Post-Structural Overhaul, Lonza Inc. Finds Its New Focus
1/24/2014
-
Lonza Inc. Launches Revamped Hygiene and Preservation Website that Enables Formulators to Quickly Find Suitable Products
8/29/2013
-
Lonza Inc. Issues Guidance on Infection Control Regarding Novel Coronaviruses (nCoV), Including the Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
8/29/2013
-
Lonza Inc. Issues Guidance on Infection Control and Global Influenza A (H7N9)
5/22/2013
-
Lonza Inc. Closes Ireland Site as U.S. Manufacturing Issues Causes Shortage of Ipsen's Increlex
5/1/2013
-
Another Biosimilar Product Setback? Lonza Inc. Rethinking Pact With Teva Pharmaceutical Industries Limited
4/1/2013
-
Lonza Inc., Hyglos Reach on Global Settlement Agreement for Endotoxin Detection Patents
3/20/2013